+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of lovastatin ls ursodeoxycholic acid udca and ls plus udca on bile lipid composition in patients with cholesterol ch gallstones



Effects of lovastatin ls ursodeoxycholic acid udca and ls plus udca on bile lipid composition in patients with cholesterol ch gallstones



Gastroenterology 102(4 Part 2): A319




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031166847

Download citation: RISBibTeXText


Related references

Ursodeoxycholic Acid (UDCA) Therapy of Gallstones. is Correction of Biliary Cholesterol Saturation Index According to Percentage UDCA in Bile Necessary for Prediction of Gallstone Dissolution?. Clinical Science 57(3): 26p.3-27p, 1979

Symptomatic gallstones are likely to reoccur after dissolution with ursodeoxycholic acid udca but this may be prevented by low dose udca. Gastroenterology 92(5 Part 2): 1787, 1987

Effects of ursodeoxycholic acid udca on mucin secretion of the gallbladder a mechanisms whereby udca prolongs cholesterol crystal nucleation. Gastroenterology 100(5 Part 2): A804, 1991

Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes. Alimentary Pharmacology and Therapeutics 43(2): 283-293, 2016

Increased concentration of ursodeoxycholic acid in fecal water during UDCA therapy may cause the colon cancer chemoprevention effects of UDCA by enhancing apoptosis. Gastroenterology 112(4 Suppl. ): A610, 1997

Ursodeoxycholic acid (UDCA) in the treatment of cholesterol cholelithiasis of the gallbladder and bile ducts. Polski Tygodnik Lekarski 38(7): 221-224, 1983

Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones. Tokai Journal of Experimental and Clinical Medicine 7(6): 671-683, 1982

Influence of ursodeoxycholic acid udca treatment on the formation of cholesterol monohydrate crystals cmc from cholesterol phospholipid vesicles in human gallbladder bile. Gastroenterology 100(5 Part 2): A749, 1991

Effect of ursodeoxycholic acid udca on pruritus and serum cholesterol levels in patients with cholestasis associated with syndromic paucity of intrahepatic bile ducts alagille syndrome. Hepatology 12(4 Part 2): 994, 1990

Cholesterol absorption during bile acid feeding. Effect of ursodeoxycholic acid (UDCA) administration. Gastroenterology 78(2): 214-219, 1980

A simple rapid and non invasive test of compliance to oral ursodeoxycholic acid udca therapy detection of udca sulfate a specific urinary metabolite. Hepatology 14(4 Part 2): 261A, 1991

Mo1930 Beneficial Effect of Ursodeoxycholic Acid (UDCA) and Its Derivative UDCA-Cpa in Attenuation of Functional Impairment of Esophageal Mucosa in Rat Model of Barrett's Esophagus. Gastroenterology 144(5): S-697-S-698, 2013

Changes induced by ursodeoxycholic acid udca administration on biliary and serum bile acid composition in patients with primary biliary cirrhosis pbc. Hepatology 12(4 Part 2): 995, 1990

Prolonged nucleation time nt and delayed growth of cholesterol crystals in human gallbladder bile by ursodeoxycholic acid udca treatment. Hepatology 7(5): 1139, 1987

A new amino acid derivative of ursodeoxycholate, (N-L-Glutamyl)-UDCA (UDCA-Glu), to selectively release UDCA in the colon. Anticancer Research 29(12): 4971-4979, 2010